Date Manufacturer Product Indication Biologic or Drug Reason Comments[removed] JNJ Paliperidone Palmitate Schizophrenia Drug N A[removed] BioDelivery Sciences Bema Fentanyl, which will be marketed in the US as Onsolis - Paliperidone - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2010-11-01 16:40:13 Oritavancin Medicine Biology Targanta Therapeutics Corporation Pharmacology Food and Drug Administration Methicillin-resistant Staphylococcus aureus New Drug Application Skin and skin structure infection Eli Lilly and Company Glycopeptide antibiotics Pharmaceutical sciences		Date Manufacturer Product Indication Biologic or Drug Reason/Comments[removed] JNJ Paliperidone Palmitate Schizophrenia Drug N/A[removed] BioDelivery Sciences Bema Fentanyl, which will be marketed in the US as Onsolis Add to Reading List Source URL: www.eyeonfda.com Download Document from Source Website File Size: 57,00 KB Share Document on Facebook

	Moderate-Risk Tumor A Patients Receiving Curative Therapy, % 90 DocID: QApL - View Document
	Date Manufacturer Product Indication Biologic or Drug Reason/Comments[removed] JNJ Paliperidone Palmitate Schizophrenia Drug N/A[removed] BioDelivery Sciences Bema Fentanyl, which will be marketed in the US as Onsolis DocID: ByuJ - View Document
	PDF Document DocID: 1dma - View Document
	PDF Document DocID: 1dkm - View Document
	PDF Document DocID: ZFp - View Document